澳股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

RHYTHM BIOSCIENCES LTD

0.080

0.000

成交量：5.18萬

成交額：4,148

市值：2,830.93萬

市盈率：-4.52

高：0.081

開：0.080

低：0.080

收：0.080

52周最高：0.280

52周最低：0.075

股本：3.54億

流通股本：1.88億

量比：0.34

換手率：0.03%

股息：- -

股息率：- -

每股收益(TTM):-0.018

每股收益(LYR):-0.018

淨資產收益率：-276.00%

總資產收益率：-96.19%

市淨率：7.78

市盈率(LYR):-4.52

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

RHYTHM BIOSCIENCES LTD

交易所：

ASX

成立時間：

2017

員工人數：

- -

公司地址：

Bio21 Institute,30 Flemington Road,Parkville,Victoria,Australia

官網：

http://www.rhythmbio.com

郵編：

3010

電話：

傳真：

61 3 9614 0550

簡介：

Rhythm Biosciences Limited, a medical diagnostics technology company, engages in developing and commercializing medical diagnostics technology in Australia and internationally. It is developing ColoSTAT, a test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Melbourne, Australia.

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/RHY.AU/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"RHY.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RHY.AU\",,,,,undefined,":{"symbol":"RHY.AU","market":"AU","secType":"STK","nameCN":"RHYTHM BIOSCIENCES LTD","latestPrice":0.08,"timestamp":1789539120000,"preClose":0.08,"halted":0,"volume":51808,"delay":0,"changeRate":0,"nameEN":"RHYTHM BIOSCIENCES LTD","floatShares":188306561,"shares":353866857,"eps":-0.0177,"marketStatus":"未開盤","change":0,"latestTime":"09-16 16:12:00 AEST","open":0.08,"high":0.081,"low":0.08,"amount":4148,"amplitude":0.0125,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.0177,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":0,"adr":0,"exchange":"ASX","adjPreClose":0.08,"openAndCloseTimeList":[[1789516800000,1789538400000]],"volumeRatio":0.3372363385664047,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"RHY.AU","preClose":0.08,"auctionPrice":0.08,"auctionVolume":43000,"auction":3,"marketStatus":"盘后竞价","timestamp":1789538404662}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"RHY.AU\",,,,,undefined,":{"symbol":"RHY.AU","floatShares":188306561,"roa":"-96.19%","roe":"-276.00%","lyrEps":-0.0177,"volumeRatio":0.3372363385664047,"shares":353866857,"dividePrice":0,"high":0.081,"amplitude":0.0125,"preClose":0.08,"low":0.08,"week52Low":0.075,"pbRate":"7.78","psRate":"16.26","week52High":0.28,"institutionHeld":0,"latestPrice":0.08,"eps":-0.0177,"divideRate":0,"volume":51808,"delay":0,"ttmEps":-0.0177,"open":0.08,"prevYearClose":0.135,"prevWeekClose":0.083,"prevMonthClose":0.087,"prevQuarterClose":0.091,"fiveDayClose":0.082,"twentyDayClose":0.082,"sixtyDayClose":0.093,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/RHY.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2020-07-27","symbol":"RHY.AU","type":"split","dateTimestamp":1595772000000,"forFactor":875,"toFactor":1000,"ratio":0.875}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"RHY.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":540780120,"yearFounded":2017,"address":"Bio21 Institute,30 Flemington Road,Parkville,Victoria,Australia","zipCode":"3010","officePhone":"61 3 8256 2880","officeFax":"61 3 9614 0550","fiscalYearEnd":"06-30"},"stockCompanyDetail":{"websiteUrl":"http://www.rhythmbio.com","stockEarnings":[{"period":"1week","weight":-0.0244},{"period":"1month","weight":-0.1111},{"period":"3month","weight":-0.3043},{"period":"6month","weight":-0.6},{"period":"1year","weight":-0.0588},{"period":"ytd","weight":-0.4074}],"compareEarnings":[{"period":"1week","weight":0.004},{"period":"1month","weight":-0.013},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.0818},{"period":"1year","weight":0.1003},{"period":"ytd","weight":0.0377}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Rhythm Biosciences Limited, a medical diagnostics technology company, engages in developing and commercializing medical diagnostics technology in Australia and internationally. It is developing ColoSTAT, a test for the early detection of colorectal cancer. The company was incorporated in 2017 and is headquartered in Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":-0.019703},{"month":2,"riseRate":0.222222,"avgChangeRate":-0.108597},{"month":3,"riseRate":0.333333,"avgChangeRate":0.022859},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.059946},{"month":5,"riseRate":0.222222,"avgChangeRate":-0.081738},{"month":6,"riseRate":0.666667,"avgChangeRate":0.043313},{"month":7,"riseRate":0.555556,"avgChangeRate":0.072688},{"month":8,"riseRate":0.444444,"avgChangeRate":0.143684},{"month":9,"riseRate":0.5,"avgChangeRate":0.03451},{"month":10,"riseRate":0.25,"avgChangeRate":0.184359},{"month":11,"riseRate":0.25,"avgChangeRate":0.055148},{"month":12,"riseRate":0.555556,"avgChangeRate":0.005724}],"exchange":"ASX","name":"RHYTHM BIOSCIENCES LTD","nameEN":"RHYTHM BIOSCIENCES LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"RHY.AU\",market:\"AU\",,,undefined,":null}}